ArticleClinical and experimental vaccine research2026
Cervical cancer awareness and vaccine hesitancy with respect to HPV vaccination in urban community of Faridabad, Haryana, India.
Article in Clinical and experimental vaccine research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To assess cervical cancer awareness and willingness to receive HPV vaccination among females aged 9-45 years in an urban community of Faridabad, Haryana, India. Materials and Methods: A community-based cross-sectional study was conducted among 302 female residents of Prem Nagar, Faridabad. Participants were assessed for their knowledge about cervical cancer and their willingness for HPV vaccination, screened for cervical cancer-related symptoms, and those symptomatic were referred for appropriate diagnostic evaluation. Descriptive statistics were calculated, and associations between variables were tested using chi-square tests. Results: The mean age of participants was 27.14 (standard deviation, 8.32) years; most were married 239 (79.1%). Awareness of cervical cancer was low, with only 73 (24.2%) having heard of the disease and very limited knowledge of its etiology and prevention. Awareness of HPV vaccination was extremely poor 32 (10.6%). Despite this, 219 (72.5%) expressed willingness to receive the vaccine. The main barriers among those unwilling 83 (27.5%) were lack of interest or motivation 44 (53.0%) and limited decision-making autonomy 25 (30.1%), while fear and knowledge deficits were less common. Conclusion: Awareness regarding cervical cancer and HPV vaccination was markedly inadequate in this urban community; however, willingness to accept vaccination was high. Further rollout of vaccination by government, targeted health education, community engagement, and empowerment of women in health decision-making could substantially improve vaccine uptake and prevent cervical cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.